ABCL-044 Clinical Outcomes of Commercial CD19-Targeted CAR T-Cell Therapy in Patients With Secondary Central Nervous System Lymphoma
- Resource Type
- Article
- Source
- In
Clinical Lymphoma, Myeloma and Leukemia October 2022 22 Supplement 2:S355-S355 - Subject
- Language
- ISSN
- 2152-2650